CDI is an innovative GI health company providing industry-leading diagnostic tests and tools to help physicians identify and diagnose common sources of digestive distress and functional gastrointestinal ailments.

Focused on our patient-centric principles, our cost-effective portfolio of diagnostic products results in expedited treatment, better patient outcomes, and robust cost savings for the healthcare delivery system. Our expansive portfolio includes: non-invasive at-home breath testing kits for Small Intestinal Bacterial Overgrowth (SIBO), Intestinal Methane Overgrowth (IMO), and carbohydrate malabsorption disorders, as well as IBSchek, a proprietary capillary collection test for Irritable Bowel Syndrome (IBS-D/M), and MyTotalHealth, a cloud-based healthcare platform that enables patients to manage and understand their symptoms for a range of conditions.

Operating out of our CLIA-certified laboratory, and as a FDA registered, ISO 13485 certified medical device manufacturer, we pride ourselves on our partnerships with leading health systems, hospitals, and private practices worldwide.

Your Trusted Partner for Functional GI Diagnostics

0
+
Years in business
0
Hour Turnaround Time
0
+
Medical Practices
0
+
Ordering Physicians
0
+
Tests Analyzed

Licenses & Certificates

CLIA Certificate of Compliance

Massachusetts DPH License

ISO 13485 Certificate

Maryland DPH License

Pennsylvania DPH License

Rhode Island DPH License

Health Canada MDEL License

International Partners

CDI and the Functional Gut Clinic, the United Kingdom’s first dedicated independent GI physiology service, have come together to establish a new joint venture, Functional Gut Diagnostics, a premier functional GI-focused diagnostic company offers CDI’s entire suite of testing products and services in the greater UK region.

Unilabs offers and distributes IBSchek® to patients and healthcare providers in Switzerland. Unilabs is a leading diagnostics and laboratory services company with extensive geographic coverage in Europe. Unilabs has a presence in the Czech Republic, Denmark, Finland, France, Italy, Norway, Portugal, Slovakia, Spain, Sweden, Switzerland, the United Kingdom, Dubai, and Peru.